Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurotoxic Adverse Effects of Morphine and Oxycodone in Continuous Subcutaneous Infusion for Treatment of Pain in Terminal Patients With Diminished Renal Function: a Randomized Controlled Trial

NCT03616639 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03616639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03616639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurotoxic Adverse Effects of Morphine and Oxycodone in Continuous Subcutaneous Infusion for Treatment of Pain in Terminal Patients With Diminished Renal Function: a Randomized Controlled Trial
Lead sponsor
Maastricht University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
June 4, 2018
Completion date
December 19, 2018
Enrollment
8 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pain, renal impairment, terminal illness